Growth Opportunities in the US Prenatal Genetic Testing Market, Forecast to 2021

Rising Maternal Age, Improved Screening Algorithms Catering to Healthcare Payer Requirements, and Exploration of New Business Models Will Drive Market

USD 4,950

* Required Fields

USD 4,950

PAY BY INVOICE

Be the first to review this product

Prenatal genetic tests, which are predominantly used to test disorders such as aneuploidies in chromosomes 21, 18, and 13, and carrier screens, are gaining momentum in the United States due to enhanced assay outcomes through non-invasive methodologies, increased popularity through social media channels, and the growing number of women choosing to undergo pregnancy at an advanced maternal age. The growth in demand has led to a high level of merger and acquisition activity, apart from numerous collaborations, which in turn has bolstered the product portfolio of several companies in the women’s healthcare segment. With this accelerated growth, companies are exploring new avenues to market their products, thereby strategically tying up with IVF clinics, physicians, and OBGYNs. New business models like direct to consumer (DTC) are seeing increased uptake due to ease of use and hassle-free processing. Partnerships with Big Data companies will be the next big leap in the prenatal genetic testing market, thereby providing interpretation of vast volumes of data to increase specificity and sensitivity.

Research Scope:
The key objectives of this growth opportunity study are to track the changes in the prenatal genetic testing market landscape in the United States from 2016 to 2021. The study aims to identify growth segments and disruptive companies for investment. Further, it provides an in-depth revenue and market share analysis of 4 key segments, namely, NIPT, carrier screening for cystic fibrosis, invasive tests, and miscarriage tests. The study highlights industry challenges, growth drivers and restraints, competitive developments, mergers and acquisitions, and investment opportunities. It also discusses the impact of Protecting Access to Medicare Act (PAMA) and the LDT guidelines issued by the FDA, identifies transforming business models, and makes strategic recommendations to understand market dynamics. The study also covers key trends and growth opportunities, game-changing companies, disruptive technologies, and strategic recommendations.

Key questions this study will answer include:
What are the long-term growth prospects in the market?
What are the other areas of growth outside NIPT? What are the opportunities to explore in carrier screening and miscarriage screening?
What are some of the innovative companies to action and to follow?
How should you price your tests to remain competitive in the market?
Who are the established market participants and what are their strategies to remain competent in this market?

Table of Contents

1. Executive Dashboard
Purpose of This Experiential Study
5-step Process to Transformational Growth
Scope and Segmentation
Segment Overview
Market Engineering Measurements
Market Snapshot
5 Major Growth Opportunities
Strategic Imperatives for Prenatal Genetic Test Providers
2. Growth Environment—Market Overview
Methodology
Market Definition—Prenatal Genetic Tests
Prevalence of Fetal Chromosomal Aneuploidies
Prenatal Tests Based on Trimesters
Value Chain
Major Regulatory Developments and Future Implications
Drivers and Restraints
3. Growth Environment—Market Forecast
Market Engineering Measurements
Revenue Forecast
Market Share by Type of Prenatal Genetic Tests
4. Growth Environment—Competitive Playbook
Prenatal Genetic Test Service Provider Landscape
Competitive Factors and Assessment
Service Provider Landscape by Key Portfolio and Technology
5. Growth Environment—NIPT
Market Overview
Revenue Forecast
Snapshot of Key Market Participants
NIPT Volumes
Market Share by Top Competitors
6. Growth Environment—Carrier Screening Test for Cystic Fibrosis
Market Overview
Revenue Forecast
Snapshot of Key Market Participants
7. Growth Environment—Invasive Prenatal Diagnostic Test
Market Overview
Revenue Forecast
Snapshot of Key Market Participants
8. Growth Environment—Miscarriage Test
Market Overview
Revenue Forecast
Snapshot of Key Market Participants
9. Visioning Scenarios
Macro to Micro Visioning
Trend Analysis in Prenatal Genetic Testing
Key Merger, Acquisition, and Partnership Assessment
Disruptive Concepts, Launches, and Portfolio Diversifications
10. Growth Opportunities
Growth Opportunity 1—Shift to NGS-based Tests with Present Adoption Rate of 60-65%
Growth Opportunity 2—Targeting Pregnant Women above the Age of 35
Growth Opportunity 3—Targeting Physicians and Genetic Counselors for Channel Marketing
Growth Opportunity 4—Bolstering Marketing Strategies by Providing Tieups with Pharmacies (CVS, Walgreens), IVD Clinics, and Retail Partners like Amazon
Growth Opportunity 5—Preparing Strategies Based on PAMA Regulations, LDT Guidelines and Healthcare Payer Policies
Growth Opportunity Matrix
11. Conclusion
Top Predictions
Legal Disclaimer
12. Appendix
Abbreviations and Acronyms Used
List of Major Prenatal Genetic Testing Companies
Details Regarding the Various Technologies Used by Companies
NIPT Process
CF Carrier Screen Testing Process
Invasive Testing Process
Miscarriage Testing Process

Infographic



List of Figures & Charts

1. Prenatal Genetic Testing Market: Prevalence of Fetal Chromosomal Aneuploidies, US, 2016
2. Prenatal Genetic Testing Market: Value Chain, US, 2016
3. Impact of PAMA on LDT Pricing, US, 2018
4. Impact of FDA on LDT Regulation, US, 2017
5. Impact of FDA on DTC Regulation, US, 2017
6. Prenatal Genetic Testing Market: Key Drivers and Restraints, US, 2017–2021
7. Prenatal Genetic Testing Market: Market Engineering Measurements, US, 2016
8. Prenatal Genetic Testing Market: Key Service Providers, US, 2016
9. Prenatal Genetic Testing Market: Trends Ranked in Importance of Key Competitive Factors, US, 2016
10. Prenatal Genetic Testing Market: Key Companies by Portfolio and Technology, US, 2016
11. NIPT Market: Accuracy in Detection Rate of Genetic Abnormalities Using Various Methods During Pregnancy, US, 2016
12. NIPT Market: Multi-faceted Growth, US, 2016–2021
13. NIPT Market: Key Participants, US, 2016
14. NIPT Market: Key Companies Providing NIPT and their Estimated Test Volumes, US, 2016
15. Cystic Fibrosis Carrier Screening Testing Market: Multi-faceted Growth, US, 2016–2021
16. Cystic Fibrosis Carrier Screening Testing Market: Key Participants, US, 2016
17. Invasive Prenatal Testing Market: Comparison between Prenatal Invasive Tests: Amniocentesis and CVS, US, 2016
18. Invasive Prenatal Testing Market: Slow Growth, US, 2016–2021
19. Miscarriage Testing Market: Multi-faceted Growth, US, 2016–2021
20. Miscarriage Testing Market: Key Participants, US, 2016
21. Prenatal Genetic Testing Market: Key Merger, Acquisition, and Partnership Assessment, US, 2013–2016
22. Prenatal Genetic Testing Market: Growth Opportunity Matrix, US, 2016
23. Prenatal Genetic Testing Market: Details Regarding Various Technologies Used by Companies, US, 2016


1. Prenatal Genetic Testing Market: Market Engineering Measurements, US, 2016
2. Prenatal Genetic Testing Market: Revenue Forecast, US, 2016–2021
3. Prenatal Genetic Testing Market: Market Share by Type, US, 2016 and 2021
4. NIPT Market: Accuracy in Detection Rate of Genetic Abnormalities Using Various Methods During Pregnancy, US, 2016
5. NIPT Market: Revenue Forecast, US, 2016–2021
6. NIPT Market: Test Volume Breakdown, US, 2016
7. Cystic Fibrosis Carrier Screening Testing Market: Revenue Forecast, US, 2016–2021
8. Invasive Prenatal Testing Market: Revenue Forecast, US, 2016–2021
9. Miscarriage Testing Market: Revenue Forecast, US, 2016–2021



Keyword1

Keyword2

Keyword3

Related Research

Release Date : 15-Nov-16

Region : North America

Release Date : 12-Sep-16

Region : North America

Release Date : 07-Apr-2015

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.